All News about Morphosys Ag ADR
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_4182.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
November 11, 2021
From MorphoSys AG
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
MorphoSys Announces Departure of Roland Wandeler
November 09, 2021
From MorphoSys AG
Via AccessWire
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2398.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_364.jpg)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_86.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_384.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-1884758_1920_101.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg?v=0)
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer's Disease
October 11, 2021
From MorphoSys AG
Via AccessWire
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2603.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_378.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-2815640_1920_1_12.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_376.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1636.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_374.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_575.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_92.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_373.jpg)
![](https://mms.businesswire.com/media/20210826005704/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_372.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1501.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/18790.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_367.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
MorphoSys AG (MOR) Q2 2021 Earnings Call Transcript
July 31, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.